The Beneluxa Initiative believes the current developments in the pharmaceutical system require coordination - to safeguard long-term affordable pharmaceutical care for European patients, while providing a strong and targeted approach to innovation in Europe. We call for: Deeper...
The Beneluxa Initiative aims to ensure sustainable access
to innovative medicine at affordable cost for our patients.
Statement of the Beneluxa Initiative on a more unified European approach to access to and affordability of pharmaceutical products
The Beneluxa Initiative identified impactful medicines suitable for joint HTA submission
Products on this list have been selected as they are of interest for a joint HTA only or combined with a joint negotiation to three or more countries within Beneluxa. The list draws from the work under IHSI high impact reports and ongoing products under the scope of the EU HTA...
Steering Committee Meeting and General Assembly of the Beneluxa Initiative in Dublin, Ireland
On 13 and 14 January 2026, Ireland kindly hosted representatives of the Beneluxa Initiative in Dublin for the biannual Steering Committee Meeting and the annual General Assembly. The meetings provided an opportunity for member states to take stock of current work, discuss current...